Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C

Hepatology

Volumn 28, Issue 5, 1998, Pages 1424-1429

  Peck Radosavljevic, Markus ^a,d   Wichlas, Martina ^a   Pidlich, Johann ^a   Sims, Paul ^b   Meng, Gloria ^b   Zacherl, Johannes ^a   Garg, Shaily ^b   Datz, Christian ^c   Gangl, Alfred ^a   Ferenci, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b GENENTECH INC   (United States)

^c Department of Internal Medicine I ^*  (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLATELET COUNT; RNA, MESSENGER; THROMBOCYTOPENIA; THROMBOPOIETIN; TUMOR CELLS, CULTURED;

EID: 17344363971     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280535     Document Type: Article

References (22)

1. Wong DK, Cheung AM, K OR, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312-323.
2. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995;332:1457-1462.
3. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356.
4. Shrestha R, McKinley C, Bilir BM, Everson GT. Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Am J Gastroenterol 1995;90:1146-1147.
5. López Morante AJ, Sáez-Royuela F, Casanova Valero F, Yuguero del Moral L, Martin Lorente JL, Ojeda Giménez C. Immune thrombocytopenia after alpha-interferon therapy in a patient with chronic hepatitis C. Am J Gastroenterol 1992;87:809-810.
6. Pardo M, Marriott E, Moliner MC, Quiroga JA, Carreno V. Risks and benefits of interferon-alpha in the treatment of hepatitis. Drug Saf 1995;13:304-316.
7. Ganser A, Carlo-Stella C, Greher J, Völkers B, Hoelzer D. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood 1987;70:1173-1179.
8. Hoofnagle JH. Thrombocytopenia during interferon alfa therapy. Jama 1991;266:849.
9. Ernstoff MS, Kirkwood JM. Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. Am J Med 1984;76:593-596.
10. Peck Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, Steininger R, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997;27:127-131.
11. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker Franklin D, et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A 1995;92:3234-3238.
12. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
13. Kuter DJ. Thrombopoiesis and thrombopoietins. In: Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D. Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology. 1st Ed. Humana Press, 1997:377-395.
14. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996;87:567-573.
15. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-2730.
16. Martin TG, 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997;127:285-288.
17. Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, et al. Dose increase augments response rate to interferon-α in chronic hepatitis C. Dig Dis Sci 1996;41:103S-108S.
18. Hino M, Nishizawa Y, Tagawa S, Yamane T, Morii H, Tatsumi N. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 1995;217:475-481.
19. Lau JY, Sheron N, Morris AG, Bomford AB, Alexander GJ, Williams R. Interferon-alpha receptor expression and regulation in chronic hepatitis B virus infection. HEPATOLOGY 1991;13:332-338.
20. Meng YG, Martin TG, Peterson ML, Shuman MA, Cohen RL, Wong WL. Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol 1996;95:535-541.
21. Radosavljevic M, Lin-Lee YC, Soyal SM, Strobl W, Seelos C, Gotto AM, Jr., Patsch W. Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver. Atherosclerosis 1992;95:147-156.
22. Hybridization of Nucleic Acids. In: Sambrook J, Fritsch F, Maniatis T. Molecular Cloning. A Laboratory Manual. 2nd Ed. Cold Spring Harbor Laboratory Press, 1989:7.52.